Literature DB >> 2660074

Isolation of ret proto-oncogene cDNA with an amino-terminal signal sequence.

M Takahashi1, Y Buma, H Hiai.   

Abstract

Our recent studies suggested that the ret proto-oncogene protein is a cell surface receptor with a tyrosine kinase domain. However, the sequence of its cDNA lacked an amino-terminal signal sequence characteristic of membrane proteins. In the present study we have isolated and sequenced an additional cDNA clone. The nucleotide sequence of the cDNA obtained indicated that the 5' terminal 330 nucleotides differs from the published sequence of the ret proto-oncogene. In addition, the sequence contains an open reading frame with an amino-terminal signal sequence.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2660074

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  30 in total

1.  A human model for multigenic inheritance: phenotypic expression in Hirschsprung disease requires both the RET gene and a new 9q31 locus.

Authors:  S Bolk; A Pelet; R M Hofstra; M Angrist; R Salomon; D Croaker; C H Buys; S Lyonnet; A Chakravarti
Journal:  Proc Natl Acad Sci U S A       Date:  2000-01-04       Impact factor: 11.205

Review 2.  [Molecular biology, basic research and diagnosis of Hirschsprung's disease].

Authors:  G Martucciello; O Luinetti; P Romano; U Magrini
Journal:  Pathologe       Date:  2007-03       Impact factor: 1.011

3.  Mutations in the extracellular domain cause RET loss of function by a dominant negative mechanism.

Authors:  M P Cosma; M Cardone; F Carlomagno; V Colantuoni
Journal:  Mol Cell Biol       Date:  1998-06       Impact factor: 4.272

Review 4.  An analysis of vertebrate mRNA sequences: intimations of translational control.

Authors:  M Kozak
Journal:  J Cell Biol       Date:  1991-11       Impact factor: 10.539

Review 5.  The RET proto-oncogene: a challenge to our understanding of disease pathogenesis.

Authors:  T Kusafuka; P Puri
Journal:  Pediatr Surg Int       Date:  1997       Impact factor: 1.827

6.  Investigation of protein refolding using a fractional factorial screen: a study of reagent effects and interactions.

Authors:  Melissa Swope Willis; James K Hogan; Prakash Prabhakar; Xun Liu; Kuenhi Tsai; Yunyi Wei; Ted Fox
Journal:  Protein Sci       Date:  2005-06-03       Impact factor: 6.725

7.  Ret oncogene activation in human thyroid neoplasms is restricted to the papillary cancer subtype.

Authors:  M Santoro; F Carlomagno; I D Hay; M A Herrmann; M Grieco; R Melillo; M A Pierotti; I Bongarzone; G Della Porta; N Berger
Journal:  J Clin Invest       Date:  1992-05       Impact factor: 14.808

8.  Functional RET G691S polymorphism in cutaneous malignant melanoma.

Authors:  N Narita; A Tanemura; R Murali; R A Scolyer; S Huang; T Arigami; S Yanagita; K K Chong; J F Thompson; D L Morton; D S Hoon
Journal:  Oncogene       Date:  2009-06-29       Impact factor: 9.867

9.  Parent-of-origin effects in multiple endocrine neoplasia type 2B.

Authors:  K M Carlson; J Bracamontes; C E Jackson; R Clark; A Lacroix; S A Wells; P J Goodfellow
Journal:  Am J Hum Genet       Date:  1994-12       Impact factor: 11.025

10.  Detection of RET proto-oncogene point mutations in paraffin-embedded pheochromocytoma specimens by nonradioactive single-strand conformation polymorphism analysis and direct sequencing.

Authors:  P Komminoth; E Kunz; O Hiort; S Schröder; X Matias-Guiu; G Christiansen; J Roth; P U Heitz
Journal:  Am J Pathol       Date:  1994-10       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.